Advertisement
Guest User

Untitled

a guest
Jan 18th, 2014
893
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 9.28 KB | None | 0 0
  1. http://www.ncbi.nlm.nih.gov/pubmed/21623535
  2. A positive association found between autism prevalence and childhood vaccination uptake across the U.S. population.
  3.  
  4. http://www.ncbi.nlm.nih.gov/pubmed/24354891
  5. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.
  6.  
  7. http://www.ncbi.nlm.nih.gov/pubmed/21058170
  8. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002.
  9.  
  10. http://www.ncbi.nlm.nih.gov/pubmed/16807526
  11. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
  12.  
  13. http://www.ncbi.nlm.nih.gov/pubmed/15795695
  14. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
  15.  
  16. http://www.ncbi.nlm.nih.gov/pubmed/22099159
  17. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
  18.  
  19. http://www.ncbi.nlm.nih.gov/pubmed/16733480
  20. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
  21.  
  22. http://www.ncbi.nlm.nih.gov/pubmed/15764492
  23. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
  24.  
  25. http://www.ncbi.nlm.nih.gov/pubmed/12773696
  26. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
  27.  
  28. http://www.ncbi.nlm.nih.gov/pubmed/18482737
  29. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
  30.  
  31. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547435/
  32. Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990–2010
  33.  
  34. http://www.ncbi.nlm.nih.gov/pubmed/21350943
  35. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.
  36.  
  37. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364648/
  38. What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?
  39.  
  40. http://www.ncbi.nlm.nih.gov/pubmed/19205900
  41. Are toxic biometals destroying your children's future?
  42.  
  43. http://www.ncbi.nlm.nih.gov/pubmed/17454560
  44. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.
  45.  
  46. http://www.ncbi.nlm.nih.gov/pubmed/19106436
  47. A comprehensive review of mercury provoked autism.
  48.  
  49. http://www.ncbi.nlm.nih.gov/pubmed/14534046
  50. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
  51.  
  52. http://www.ncbi.nlm.nih.gov/pubmed/19357975
  53. Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection.
  54.  
  55. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774468/
  56. Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism
  57.  
  58. http://www.ncbi.nlm.nih.gov/pubmed/16766480
  59. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
  60.  
  61. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697751/
  62. B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal
  63.  
  64. http://www.ncbi.nlm.nih.gov/pubmed/21299355
  65. Theoretical aspects of autism: causes--a review.
  66.  
  67. http://www.ncbi.nlm.nih.gov/pubmed/15869795
  68. Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH).
  69.  
  70. http://www.ncbi.nlm.nih.gov/pubmed/16273274
  71. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria.
  72.  
  73. http://www.ncbi.nlm.nih.gov/pubmed/21225508
  74. Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal.
  75.  
  76. http://www.ncbi.nlm.nih.gov/pubmed/22015705
  77. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.
  78.  
  79. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957583/
  80. Neonatal Administration of Thimerosal Causes Persistent Changes in Mu Opioid Receptors in the Rat Brain
  81.  
  82. http://www.ncbi.nlm.nih.gov/pubmed/24235069
  83. Effect of thimerosal on the neurodevelopment of premature rats.
  84.  
  85. http://www.ncbi.nlm.nih.gov/pubmed/21549155
  86. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.
  87.  
  88. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264864/?tool=pubmed
  89. Administration of Thimerosal to Infant Rats Increases Overflow of Glutamate and Aspartate in the Prefrontal Cortex: Protective Role of Dehydroepiandrosterone Sulfate
  90.  
  91. http://www.ncbi.nlm.nih.gov/pubmed/21907498
  92. Conjugate vaccines and autism.
  93.  
  94. http://www.ncbi.nlm.nih.gov/pubmed/19756911
  95. Are neuropathological conditions relevant to ethylmercury exposure?
  96.  
  97. http://www.ncbi.nlm.nih.gov/pubmed/11339848
  98. Autism: a novel form of mercury poisoning.
  99.  
  100. http://www.ncbi.nlm.nih.gov/pubmed/23069197
  101. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.
  102.  
  103. http://www.ncbi.nlm.nih.gov/pubmed/21993250
  104. Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders.
  105.  
  106. http://www.ncbi.nlm.nih.gov/pubmed/17114826
  107. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.
  108.  
  109. http://www.ncbi.nlm.nih.gov/pubmed/23609067
  110. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.
  111.  
  112. http://www.ncbi.nlm.nih.gov/pubmed/23932735
  113. Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes.
  114.  
  115. http://www.ncbi.nlm.nih.gov/pubmed/20638374
  116. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
  117.  
  118. http://www.ncbi.nlm.nih.gov/pubmed/17674242
  119. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.
  120.  
  121. http://www.ncbi.nlm.nih.gov/pubmed/15527868
  122. Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors.
  123.  
  124. http://www.ncbi.nlm.nih.gov/pubmed/15780490
  125. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity.
  126.  
  127. http://www.ncbi.nlm.nih.gov/pubmed/12933322
  128. Reduced levels of mercury in first baby haircuts of autistic children.
  129.  
  130. http://www.ncbi.nlm.nih.gov/pubmed/12145534
  131. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.
  132.  
  133. http://www.ncbi.nlm.nih.gov/pubmed/14745455
  134. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal.
  135.  
  136. http://www.ncbi.nlm.nih.gov/pubmed/16870260
  137. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge.
  138.  
  139. http://www.ncbi.nlm.nih.gov/pubmed/15446387
  140. Neurologic complications of immunization.
  141.  
  142. http://www.ncbi.nlm.nih.gov/pubmed/22249285
  143. Hepatitis B vaccine induces apoptotic death in Hepa1-6 cells.
  144.  
  145. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395253/
  146. Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA
  147.  
  148. http://www.ncbi.nlm.nih.gov/pubmed/?term=Neonatal+administration+of+a+vaccine+preservative%2C+thimerosal%2C+produces+lasting+impairment+of+nociception+and+apparent+activation+of+opioid+system+in+rats.
  149. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats.
  150.  
  151. http://www.ncbi.nlm.nih.gov/pubmed/19043938
  152. A possible central mechanism in autism spectrum disorders, part 1.
  153.  
  154. http://www.ncbi.nlm.nih.gov/pubmed/12142947
  155. The role of mercury in the pathogenesis of autism.
  156.  
  157. http://www.ncbi.nlm.nih.gov/pubmed/20628439
  158. Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study.
  159.  
  160. http://www.ncbi.nlm.nih.gov/pubmed/10648110
  161. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
  162.  
  163. http://www.ncbi.nlm.nih.gov/pubmed/20457211
  164.  
  165.  
  166. http://people.csail.mit.edu/seneff/Entropy/entropy-14-02227.pdf
  167. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure
  168.  
  169. http://www.tandfonline.com/doi/abs/10.1080/02772240701806501#preview
  170. Hepatitis B triple series vaccine and developmental disability in US children aged 1–9 years
  171.  
  172. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027897?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosone%2FPediatricsandChildHealth+%28PLoS+ONE+Alerts%3A+Pediatrics+and+Child+Health%29
  173. Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis
  174.  
  175. http://digitalcommons.pace.edu/pelr/vol28/iss2/6/
  176. Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement